FDA Warning Letter — Hubei Kangzheng Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Hubei Kangzheng Pharmaceutical Co., Ltd. on November 23, 2021 (Anlu, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Hubei Kangzheng Pharmaceutical Co., Ltd.
- Date
- November 23, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- Anlu (China)